Cardiovascular risks associated with second-line oral antidiabetic agents added to metformin in patients with Type 2 diabetes: a nationwide cohort study
Journal
Diabetic medicine : a journal of the British Diabetic Association
Journal Volume
32
Journal Issue
11
Pages
1460
Date Issued
2015-11
Author(s)
Abstract
To compare the cardiovascular risks associated with second-line oral antidiabetic agents added to initial metformin therapy in a large nationwide observational study.
Subjects
CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION; GLUCOSE-CONCENTRATION; HYPOGLYCEMIC AGENTS; PIOGLITAZONE; METAANALYSIS; MORTALITY; REPAGLINIDE; MELLITUS; OUTCOMES
SDGs
Publisher
WILEY
Type
journal article